✦ LIBER ✦

Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A

✍ Scribed by S. DELIGNAT; Y. REPESSÉ; A. -M. NAVARRETE; Y. MESLIER; N. GUPTA; O. D. CHRISTOPHE; S. V. KAVERI; S. LACROIX-DESMAZES

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

von Willebrand factor in factor VIII con

✍ A. Kallas; T. Talpsep 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Inhibitor development in haemophilia A:

✍ J. GOUDEMAND 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Characterization of von willebrand facto

✍ William A. Fricke; Mei-Ying Wong Yu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Immune tolerance therapy utilizing facto

✍ M. A. H. KURTH; D. DIMICHELE; C. SEXAUER; J. M. SANDERS; M. TORRES; S. C. ZAPPA; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Pharmacokinetics and hemostatic effect o

✍ S. Lethagen; E. Berntorp; I. M. Nilsson 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 969 KB

Pharmacokinetics of Optivate®, a high-pu

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB